Search Results
Assessment of continuous vaginal logger-based temperature monitoring in fever-induced gilts
2013, Schmidt, Mariana, Ammon, Christian, Schon, Peter, Manteuffel, Christian, Hoffmann, Gundula
The aim of this study was to identify a low risk method to induce fever in gilts and to evaluate vaginal sensors for temperature monitoring. Therefore, a rhinitis atrophicans vaccine was used to induce fever to evaluate sensors and behavioral patterns. During 11 trials, two of four animals were injected with 2 mL of the vaccine Porcilis AR-T DF (Intervet) and the other two animals were treated with 2 mL of 0.9% NaCl as controls. A temperature logger (TRIX-8, LogTag Recorders, Auckland, New Zealand) was used to continuously monitor the vaginal temperature. Additionally, rectal temperatures were measured four times daily. The water consumption, food intake and locomotion behaviors of the animals were analysed one day before treatment and during the day of the treatment. The vaccine induced fever in all gilts, which occurred approximately 5.87 h after vaccination. The vaginal logger temperatures and the rectal temperatures showed a linear correlation in 21 vaccinated gilts (r = 0.86; p<0.0001) and 22 non-vaccinated gilts (r = 0.65; P<0.0001). The vaginal logger can be continuously used to measure the core temperature. Water intake decreased (p<0.0001) in the gilts with fever, whereas food intake did not change (p = 0.9411). The vaccinated gilts spent 79±16 more minutes per day lying after the vaccination (p<0.001) in comparison to the day before the vaccination. Treatment with this vaccine provides the opportunity to induce fever over a short time period (5.13 h) and mild sickness behavior in gilts to investigate disease indicators.
3D-Printing of Structure-Controlled Antigen Nanoparticles for Vaccine Delivery
2020, Nishiguchi, Akihiro, Shima, Fumiaki, Singh, Smriti, Akashi, Mitsuru, Moeller, Martin
Targeted delivery of antigens to immune cells using micro/nanocarriers may serve as a therapeutic application for vaccination. However, synthetic carriers have potential drawbacks including cytotoxicity, low encapsulation efficiency of antigen, and lack of a morphological design, which limit the translation of the delivery system to clinical use. Here, we report a carrier-free and three-dimensional (3D)-shape-designed antigen nanoparticle by multiphoton lithography-based 3D-printing. This simple, versatile 3D-printing approach provides freedom for the precise design of particle shapes with a nanoscale resolution. Importantly, shape-designed antigen nanoparticles with distinct aspect ratios show shape-dependent immune responses. The 3D-printing approach for the rational design of nanomaterials with increasing safety, complexity, and efficacy offers an emerging platform to develop vaccine delivery systems and mechanistic understanding.